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Concussion Guidelines Step 1: Systematic Review of
Prevalent Indicators
BACKGROUND: Currently, there is no evidence-based definition for concussion that is
being uniformly applied in clinical and research settings.
OBJECTIVE: To conduct a systematic review of the highest-quality literature about
concussion and to assemble evidence about the prevalence and associations of key in-
dicators of concussion. The goal was to establish an evidence-based foundation from
which to derive, in future work, a definition, diagnostic criteria, and prognostic indicators
for concussion.
METHODS: Key questions were developed, and an electronic literature search from
1980 to 2012 was conducted to acquire evidence about the prevalence of and asso-
ciations among signs, symptoms, and neurologic and cognitive deficits in samples of
individuals exposed to potential concussive events. Included studies were assessed for
potential for bias and confound and rated as high, medium, or low potential for bias
and confound. Those rated as high were excluded from the analysis. Studies were
further triaged on the basis of whether the definition of a case of concussion was
exclusive or inclusive; only those with wide, inclusive case definitions were used in the
analysis. Finally, only studies reporting data collected at fixed time points were used.
For a study to be included in the conclusions, it was required that the presence of any
particular sign, symptom, or deficit be reported in at least 2 independent samples.
RESULTS: From 5437 abstracts, 1362 full-text publications were reviewed, of which 231
studies were included in the final library. Twenty-six met all criteria required to be used
in the analysis, and of those, 11 independent samples from 8 publications directly
contributed data to conclusions. Prevalent and consistent indicators of concussion are
(1) observed and documented disorientation or confusion immediately after the event,
(2) impaired balance within 1 day after injury, (3) slower reaction time within 2 days
after injury, and/or (4) impaired verbal learning and memory within 2 days after injury.
CONCLUSION: The results of this systematic review identify the consistent and prev-
alent indicators of concussion and their associations, derived from the strongest evi-
dence in the published literature. The product is an evidence-based foundation from
which to develop diagnostic criteria and prognostic indicators.
KEY WORDS: Concussion, Indicators of concussion, Systematic review
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T
his is the first in a series of reports that are
intended to build an evidence base for
a definition, diagnostic criteria, and prognos-
tic indicators for concussion.The initial goal of Step
1 was to derive an evidence-based definition for
concussion using data from the highest-quality
published literature. Currently, there is no defini-
tion for concussion that is being uniformly applied
in clinical and research settings.1
A general approach for deriving a definition
was constructed: A systematic review of the
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literature would be conducted to identify the prevalence of signs,
symptoms, neurologic deficits, and cognitive deficits (SSDs) after
potential concussive events (PCEs) in athletic, hospital, and
military populations. (For the purposes of this report, prevalence
is the proportion of the sample with the particular sign, symptom,
or deficit being discussed at the particular time point of
measurement. In reports of data from studies used to support
the conclusions, the absolute prevalence, that is, the difference
between the prevalence of the sign, symptom, or deficit in the
potentially concussed group compared with control subjects
[either self or control group], is used.) The goal was to determine
who (which patients) had what (which signs, symptoms, and
deficits) when (at what specific time points). The product would
be analyses of the frequencies of indicators of concussion at specific
time points and of their associations. Using only high-quality
studies, the product would provide a simple but concrete evidence-
based foundation on which to develop a definition.
A multidisciplinary Panel of Technical Experts was assembled,
and the project was initiated with a preliminary survey of the
current literature about concussion. The survey revealed pervasive
circularity in the relationship between case identification and
outcome reporting for individual studies. That is, in most of the
published literature, criteria for a definition of a case of concussion
were prespecified, and then patients were selected on the basis of
those criteria. Thus, data on the prevalence of the criteria as
outcomes in those samples are overestimated and are not useful for
deriving a definition (eg, not useful for knowing “who had what,
when”). There is, however, a subset of studies that use broadly
inclusive case definitions. Their samples consist of participants
involved in some PCE with or without loss of consciousness
(LOC), with or without posttraumatic amnesia (PTA), with at
least 1 symptom such as disorientation, headache, nausea,
dizziness, blurred vision, or altered mental state. Operationally,
such a definition would include almost any individual involved
in some form of PCE. For this report, only publications with
the most inclusive case definitions were used in the analyses.
(Complete details on how studies were selected are provided
in the Methods section of this document.) The benefit of
this approach is an increased likelihood that most of the true
concussions were included in the samples; the downside is an
increased likelihood that nonconcussed participants were also
included in the samples.
In addition, only publications that met prespecified design
characteristics and a threshold level of potential for bias were
included in the analyses (see the Methods section). Therefore, the
final library consists of 26 studies that provide sufficient replication
of data to endorse only 4 parameters as candidate attributes of
a definition for concussion. Furthermore, although current
research about imaging and biomarkers shows promise, it falls
short of providing evidence to support use of a physiologic marker
in a definition. As a result, there are insufficient data to derive
a definition for concussion at this time. Thus, the product of
Concussion Guidelines Step 1 is a Systematic Review of Prevalent
Indicators. The revised goals of Step 1 of the Concussion
Guidelines Project were to conduct a systematic review of the
literature on the occurrence of signs, symptoms, and neurologic
and cognitive deficits associatedwith concussion; to apply rigorous
inclusion/exclusion and quality assessment criteria; to include only
the studies with design and quality characteristics that would allow
at least moderate confidence in the findings; and to present
conclusions about the most prevalent indicators of concussion.
The obvious must be stated at this point. Without knowing what
concussion is, that is, without a definition, this review (“Concussion
Guidelines Step 1: Systematic Review of Prevalent Indicators”) leaves
the unanswered question, “Prevalent indicators of what?” What is
concussion? The inclusion criteria for the literature review probably
provide a corral within which concussion exists; it is likely the corral
also contains nonconcussed individuals and those with more serious
brain trauma; it also may exclude some versions of concussion.
The corral consists of the following attributes, in which
concussion:
• is a change in brain function,
• follows a force to the head,
• may be accompanied by temporary LOC,
• is identified in awake individuals, and
• includes measures of neurologic and cognitive dysfunction.
Thus, this report provides evidence-based data on indicators of
a phenomenon, as yet undefined, called concussion. This report is
not a guideline; it is the first step, the foundation for evidence-
based guidelines. It is the mandate of this group to derive
a definition, guidelines for diagnosis and prognosis, and, if
possible, treatment guidelines for concussion using research for
which there is at least moderate confidence in the findings. To that
end, future work will include ongoing review of new studies,
reanalysis of existing data sets with a focus on the prevalence of
indicators and their associations with objective measures, design
and validation of diagnostic and prognostic models, and genera-
tion of new prospective studies targeting gaps in information that
must be filled.
The following report is a summary of a comprehensive review
and analysis process. The detailed analysis, with supporting tables
and graphs, can be found in the Supplemental Digital Content
(available at http://links.lww.com/NEU/A633, http://links.lww.
com/NEU/A634, http://links.lww.com/NEU/A635, http://
links.lww.com/NEU/A636, http://links.lww.com/NEU/A637,
http://links.lww.com/NEU/A638, http://links.lww.com/NEU/
A639, http://links.lww.com/NEU/A640, http://links.lww.com/
NEU/A641, http://links.lww.com/NEU/A642, http://links.lww.
com/NEU/A643, http://links.lww.com/NEU/A644, http://
links.lww.com/NEU/A645, http://links.lww.com/NEU/A646,
http://links.lww.com/NEU/A647).
METHODS
Structure of the Research Team
Subgroups of the research team include an Executive Committee,
a Methods Group, and a Panel of Technical Experts. The Executive
Committee includes Jamshid Ghajar, MD, PhD; Andy Jagoda, MD;
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Silvana Riggio, MD; Nancy Carney, PhD; Lisa McGuire, PhD; and
Victor Coronado, MD. The Methods Group, from Oregon Health &
Science University, includes Nancy Carney, PhD; Cynthia Davis-
O’Reilly, BSc; Amy Huddleston, MPA; Nora Helfand; Steven Bedrick,
PhD; Tracie Nettleton, MS; and Hugo du Coudray, PhD. Members of
the Panel of Technical Experts are listed in Supplemental Digital
Content 1, Task Force (http://links.lww.com/NEU/A633). There is no
formal hierarchical relationship among the 3 subgroups.
Panel of Technical Experts
Individuals with clinical and research expertise in concussion who also
represent stakeholder organizations were invited to participate as
members of a Panel of Technical Experts. Also included were
representatives from the Department of Defense and the Centers for
Disease Control and Prevention. Six meetings were held at 3- to
4-month intervals. At the first meeting, recommendations for the
parameters of the project were presented, and the panel provided
feedback. The parameters were revised according to panel recommen-
dations, and the revised scope document was circulated after themeeting
for panel endorsement.
Role of the Funder
This project was funded by the US Army Contracting Command,
which was represented on the Panel of Technical Experts. In addition, the
BrainTrauma Foundation provided funding for 2meetings of the Panel of
Technical Experts.
Objectives and Scope
The objective was to conduct a systematic review of the literature about
the SSDs associated with concussion. The goal was to identify the most
prevalent indicators of concussion and their associations. To that end, the
literature search was wide and inclusive, and the inclusion/exclusion
criteria were highly specific.
Key Questions
Key questions for the review were articulated to provide a structure for
acquiring data on the signs, symptoms, and deficits of concussion:
Key Question 1. What are the most common signs, symptoms, and
neurologic and cognitive deficits within 3 months after a PCE?
Key Question 2. Does the presence of signs, symptoms, and deficits
within 3 months of a PCE vary by demographics, premorbid condi-
tions, comorbidities, mechanism of injury, case definition, or other
factors independent of the PCE?
Key Question 3. What is the association between different signs,
symptoms, and deficits or between the same signs, symptoms, or
deficits at different time points for the same patient after a PCE?
Key Question 4. What is the relationship between signs, symptoms, and
deficits and imaging or biomarkers after a PCE?
Literature Search and Review
A PhD-level research librarian conducted an electronic search from
1980 to September 2012 in Medline, Sports Discus, PsychINFO, and
Cochrane. Rationale for the beginning date included limiting to literature
generated after the introduction of computerized tomography (CT) scan
technology and scoping the project to emphasize the most current data.
Reference lists of review articles were compared with the list captured in
the electronic search, and abstracts for those not captured were acquired
and reviewed for eligibility. Publications referred by colleagues or by
clinical expert participants were also reviewed and included if eligible. The
publications not acquired with the electronic search were used to rewrite
the original strategy and to rerun the search to acquire other studies that
might have been missed (see Supplemental Digital Content 2, Search
Strategy, http://links.lww.com/NEU/A634).
Abstracts were read by 2 assessors from the Methods Group. The dual
coding was compared, and discrepancies were resolved through consen-
sus or by a third reviewer. Full-text publications were acquired for all
included abstracts. One assessor read each publication and specified its
inclusion/exclusion status. A second assessor, not blinded to the
specification, read the publication to confirm or disagree. Discrepancies
were resolved through consensus or by a third reviewer.
Data Abstraction
Supplemental Digital Content 3, Data Points From Abstraction
Instrument (http://links.lww.com/NEU/A635), contains the data points
abstracted from each included publication. One person from the
Methods Group performed the primary abstraction, and a second
person checked the work. Data for the category “ascertainment of signs/
symptoms/neurologic deficits/cognitive deficits” were abstracted only for
the publications rated as medium potential for bias (see the Quality
Assessment section).
Quality Assessment
The focus of the categorization of the quality of individual studies
was the assessment of potential for bias and confound. An instrument
developed by investigators of the Oregon Evidence-Based Practice
Center was used for rating potential for bias and confound in observational
studies (see Supplemental Digital Content 4, Instrument to Assess
Potential For Bias and Confound, http://links.lww.com/NEU/A636).
The instrument addresses 7 domains:
• Selection bias
• Bias resulting from missing data
• Ascertainment bias related to case definition and identification
• Ascertainment bias related to case assessment
• Ascertainment bias related to SSD description and evaluation
• Ascertainment bias related to SSD assessment
• Confounding
Scoring of individual domains was “yes” (yes, potential for bias
was minimized), “no” (no, potential for bias was not minimized), or
“unclear” (insufficient information to know if potential for bias
was minimized).
Each article was assigned an overall potential for bias rating. The overall
rating takes into consideration the scores on the individual domains but is
not an additive process using the individual scores. In assigning the overall
score, the assessor considers the existing flaws of each publication in the
context of the purpose of the study and in relation to the strengths of
the publication. Scoring of overall potential for bias was low (low potential
for bias), medium (medium potential for bias), or high (high potential
for bias).
Two members of the Methods Group, blinded to each other’s work,
used the instrument in Supplemental Digital Content 4 (Instrument to
Assess Potential For Bias and Confound, http://links.lww.com/NEU/
A636) to rate each publication. Ratings were compared and discrepancies
resolved through consensus or by a third reviewer.
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Principles Used to Identify Evidence for
Prevalent Indicators
Throughout the rest of this report, information across studies is
combined to answer the key questions and to derive conclusions. Principles
were used for combining evidence and assessing the overall quality of a body
of literature outlined in the 2010 publication, “Grading the Strength of
a Body of Evidence When Comparing Medical Interventions: Agency for
Healthcare Research and Quality and the Effective Health Care Pro-
gram.”2 Specifically, individual publications were assessed for risk of bias
and confound, and information from studies of the highest quality was
synthesized. When the data from multiple studies about a specific measure
were inconsistent across studies, the data were not used to support the
conclusions. Information derived from a single study that was not
replicated was not used to support the conclusions.
In sum, the following rules were used to identify data to specify
prevalent indicators of concussion: (1) Findings must be from .1
independent sample (replicated), from studies of medium or low
potential for bias, from studies with inclusive case definitions, and from
studies with fixed time points for reporting disease and outcome
measures. (2) Findings from single studies were reported but not used in
the conclusions. (3) Findings from multiple studies with contradictory
information were reported but were not used in the conclusions.
Detailed information about definitions, inclusion/exclusion criteria,
the protocol for identifying studies with inclusive case definitions, and the
algorithm for assessing the utility of data can be found in Supplemental
Digital Content 5, Methods (http://links.lww.com/NEU/A637).
RESULTS
Final Library of Included Publications
The multiple electronic searches and hand search methods
yielded 5592 abstracts of potentially relevant studies. Of those,
1362 full-text publications appeared to meet inclusion criteria and
were acquired and read for eligibility. Two hundred thirty-one met
the prespecified criteria, and of those, 62 publications were rated as
medium potential for bias (see Evidence Tables, Supplemental
Digital Contents 6 and 7, http://links.lww.com/NEU/A638,
http://links.lww.com/NEU/A639). Of the 62 publications, 26
had inclusive case definitions, reported data at fixed time points
relevant to 1 or more of the key questions, and were included in the
analysis. Eleven independent samples from 8 publications con-
tributed data for the conclusions. Table 1 lists the 26 studies used
in the analysis for this report. Cells indicate which study
contributed to which key question and to the conclusions.
Prevalent Indicators: Evidence Derived From Multiple
Independent Samples
The SSDs at the time points indicated that constitute the
prevalent indicators are what was found in the existing literature
from studies that met the prespecified inclusion criteria and
adhered to standards for minimizing potential for bias and
TABLE 1. Studies Included in the Analysis
Reference
Data Used For
Key Question 1 Key Question 2 Key Question 3 Key Question 4 Conclusions
Broglio et al3 X X
Broglio et al4 X X
Cavanaugh et al5 X X
Collins et al6 X X X
Collins et al7 X
Covassin et al8 X X
de Monte et al9 X X
Field et al10 X X
Geyer et al11 X
Hinton-Bayre et al12 X
Iverson et al13 X X X
Kontos et al14 X X X
Lovell et al15 X X X
Lovell et al16 X
Maddocks et al17 X
McCrea et al18 X X
McCrea et al19 X
McCrea et al20 X
Ono et al21 X
Papa et al22 X
Papa et al23 X
Saadat et al24 X
Sim et al25 X
Smits et al26 X
Turedi et al27 X
Van Kampen et al28 X X
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confound. The absence of evidence for other impairments at other
time points must not be interpreted as evidence of no impairment.
The evidence for these conclusions should be used as a starting
point from which to identify missing information as targets for
future investigation.
Sample Characteristics of Studies Used for the Conclusions
Eleven independent samples (3 independent samples are reported
in one publication by Broglio et al3 and 2 in one publication
by Field et al10) met the criteria specified in the Methods section
and contributed data to the conclusions (Table 1). All were
conducted in athletic settings; 5 included adults only,3,5,6
1 included adolescents only,15 and 5 included adults and
adolescents.10,13,14,28
Evidence-Based Indicators for Concussion
The list of evidence-based indicators for concussion is shown in
Table 2.
A summary of the evidence derived from single studies,
which may be indicators of concussion, can be found in
Supplemental Digital Content 8, Evidence From Single Studies
(http://links.lww.com/NEU/A640).
Key Question 1 Results
Key Question 1: What are the most common signs,
symptoms, and neurologic and cognitive deficits within
3 months after a PCE? (See Evidence Table, Supplemental
Digital Content 6, http://links.lww.com/NEU/A638).
Details of the analysis and results can be found in Supplemental
Digital Content 9, Analysis (http://links.lww.com/NEU/A641).
Signs
Data Synthesis. Fourteen studies containing data on signs associ-
ated with a PCE met the criteria for this analysis and were included
as evidence for this section (see Table, Supplemental Digital
Content 10, http://links.lww.com/NEU/A642). 3,6-9,12-17,19,25,28
Thirteen were studies of athletes; 6 samples were adults, 5 were
adolescents, and 3 mixed adult and adolescent subjects. The
fourteenth study included adult and pediatric patients in a hospital
environment.9 A total of 1007 participants were assessed. In 7
studies, 381 subjects served as their own controls with preinjury
baseline tests. Across 6 studies, 381 PCE subjects were compared
with 212 control subjects, and for 1 study, 20 subjects both served
as their own controls and were compared with 13 control subjects.
Results. The prevalence of LOC ranged from 1% to 14.3%
(evidence from 10 studies).3,6-8,13-15,19,25,28 The prevalence of PTA
ranged from 2% to 29.7% (evidence from 7 studies).7,13-16,19,25
The prevalence of retrograde amnesia ranged from 7.4% to
53.3% (evidence from 5 studies).7,13,15,19,28 The prevalence
of disorientation/confusion ranged from 18% to 44.7%
(evidence from 3 studies).13,15,28
Symptoms
Data Synthesis. One study containing data on symptoms after a
PCE met the criteria for this analysis and was included as evidence
for this section.17 Seven symptoms (headache, dizziness, blurred
vision, nausea, double vision, noise sensitivity, and light sensitivity)
were measured at 2 hours after injury in a sample of 28 adult
athletes and compared with the same symptoms in 28 uninjured,
matched control subjects.
Results. Statistical or clinical significance was not reported.
Proportions of PCE and control subjects with symptoms and
the absolute prevalence are reported in Table 3. Absolute
prevalence exceeded 50% for headache, dizziness, blurred
vision, and nausea. Supplemental Digital Content 11 (see
Table, http://links.lww.com/NEU/A643) lists studies included
in this review and reasons why symptoms data could not be used
in the analysis.
TABLE 2. Evidence-Based Indicators for Concussion
Indicators of concussion, observed in alerta individuals after
a force to the head, are:
Observed and documented disorientation or confusionb
immediately after the event13,15,28
Impaired balancec within 1 day after injury3,5
Slower reaction timed within 2 days after injury3,14,28
Impaired verbal learning and memorye within 2 days after
injury6,10,14,28
aAlert: Glasgow Coma Scale score of 13 to 15.
bDisorientation or confusion: loss of one’s sense of direction, position, or
relationship with one’s surroundings.
cBalance: a state of body equilibrium.
dReaction time: the interval of time between application of a stimulus and
detection of a response.
eVerbal learning and memory: the acquisition, retention, and retrieval of verbal
material; memory of words and other abstractions involving language.
TABLE 3. Proportions of Symptoms for Subjects With Potential
Concussive Events and Control Subjects
Potential Concussive
Event Subjects
(n = 28), %
Control
Subjects
(n = 28), %
Absolute
Prevalence,
%
Headache 93 18 75
Dizziness 64 4 60
Blurred
vision
75 0 75
Nausea 61 7 54
Double
vision
11 0 11
Noise
sensitivity
4 0 4
Light
sensitivity
4 0 4
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Neurologic Deficits
Data Synthesis. Four publications containing data on neurologic
deficits after a PCE met the criteria for this analysis and were
included as evidence for this section (see Table, Supplemental
Digital Content 12, http://links.lww.com/NEU/A644). 3-5,20
The only neurologic function tested was balance. All samples
were adult athletes, and samples ranged in size from 26 to
150 participants. A total of 266 participants were assessed.
In 3 studies, 116 subjects served as their own controls with
preinjury baseline testing.3-5 In the fourth study, 94 PCE subjects
were compared with 56 uninjured control subjects.20
Results. For the publications included in this analysis, measure-
ment times ranged from immediately after the event to 7 days after
injury. A total of 20measures of function using 11 neurologic tests
were performed during that time span. Ten of the tests were
conducted with the NeuroCom Sensory Organization Test
(SOT). Results of the SOT are reported by composite, somato-
sensory ratio, visual ratio, and vestibular ratio, as well as by testing
condition as well as by 6 distinct balance challenge conditions.
The eleventh test was the Balance Error Scoring System.
(Although Cavanaugh et al5 analyzed SOT data, they did not
use the SOT manufacturer’s software as their metric).
Of the 20 measures of balance, 12 (60%) showed clinically
significant differences between PCEs and comparators within
1 week of injury. For 5 measures, the results are equivocal
(see the Definitions section of Supplemental Digital Content 5,
http://links.lww.com/NEU/A637), and for 3 measures, there
was no difference. Thirty-one percent of the sample tested
immediately after the event showed clinically significant decre-
ments in function. The prevalence of decrements at 1 day ranged
from 23.8% to 36.5%. By day 2, significant decrements persisted
in 8 of 14 tests (57%), and the 1 test taken at day 7 showed no
difference.
The prevalence of balance deficits within 2 days ranged from
23.8% to 36.5% within 24 hours of injury and decreased to
between 19.2% and 24% by day 2. For balance taken at fixed time
points between days 1 and 7, 60% of the measures indicated
decrements in function in PCE subjects compared with
comparators.
Cognitive Deficits
Data Synthesis. Nine publications containing data on cognitive
deficits after a PCEmet the criteria for this analysis andwere included
as evidence for this section (see Table, Supplemental Digital
Content 13, http://links.lww.com/NEU/A645). 3,6,9,10,14,15,18,19,28
(In the Broglio et al3 report, results from 3 independent samples
were reported [n = 23, 28, and 24]. Thus, samples sizes for this
study vary in this report.) One of the 9 reported on hospital
patients9; the other 8 took place in athletic environments. Sample
sizes ranged from 16 to 122 participants. A total of 604
participants who had sustained a PCE were assessed. There were
720 control participants; 444 served as their own controls in
pretrauma baseline testing, and 276 were from “other injury” or
“no injury” comparison groups. Measurement times ranged from
immediately after the event to 7 days after injury. A total of 100
measures of function using 27 cognitive tests were performed
during that time span.
Results.
Reaction Time. The prevalence of deficits identified with
measures of reaction time ranged from 41.7% to 71.4% within
24 hours of injury and persisted through 2 days after injury to
a significant degree, although the exact prevalence is not known
beyond day 1 (evidence from 3 studies, 3 measures, 6 testing time
points).3,14,28
Attention/Processing Speed/Working Memory. The prevalence
of deficits identified with measures of attention/processing speed/
working memory, reported in the form of reliable change index
(see Supplemental Digital Content 14, Reliable Change Index,
http://links.lww.com/NEU/A646), ranged from 0% to 30.4% to
50% to 52.2% within 24 hours of injury, with no evidence that
they persist beyond this time point (evidence from 4 studies, 6
measures, 15 testing time points).3,6,18,19
Memory. Prevalence of deficits identified with measures of
memory ranged from 0% to 20.8% to 39.1% to 41.7% within 24
hours of injury, although the exact prevalence is not known
beyond day 1 (evidence from 8 studies, 12 measures, 53 testing
time points).3,6,10,14,15,18,19,28
Executive Function. Prevalence of deficits identified with
measures of executive function ranged from 0 to 34.8%, to
52.2%within 24 hours of injury, with no evidence that they persist
beyond this time point.
Motor/Sensory Function. Prevalence data are not available for
deficits identified with measures of motor/sensory function.
Global Cognitive Measures. Prevalence data are not available
for deficits identified with global cognitive measures.
Results of Tests of Cognitive Deficits Across Time. Table 4 shows
the number of tests conducted at each time point, the proportion
of tests that found differences between PCE and comparators,
and the number of studies that contributed data at each time point.
Time points were removed for which only 1 study and a limited
number of tests contributed data. Results are displayed in Figure 1.
As can be seen, the proportion of tests that showed decrements in
function decreased from 58% on day 1 to 8% on day 7.
TABLE 4. Cognitive Test Frequency by Time Point and Outcome
Tests, n Proportion Positive, % Studies, n
Immediate 5 100 1
Day 1 26 58 3
36 h 1 100 1
Day 2 15 40 3
Day 3 13 31 2
Day 4 1 100 1
Day 5 13 8 2
Day 7 25 8 5
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Results of Tests of Cognitive Deficits Across Domains. Table 5
shows the number of tests conducted for each cognitive domain,
the proportion of tests that found differences between PCE and
comparators, and the number of studies that contributed data at
each time point. One domain (global measures) for which only 1
study contributed data was removed. Results are displayed in
Figure 2. Eighty-three percent of measures of reaction time
taken between 1 and 7 days after injury indicated decrements
in function for this domain in PCE subjects vs comparators,
43% of measures of memory, and 29% of measures of attention/
processing speed/working memory.
Key Question 2 Results
Key Question 2: Does the presence of signs, symptoms,
and deficits within 3 months of a PCE vary by demographics,
premorbid conditions, comorbidities, mechanism of injury,
case definition, or other factors independent of the
PCE? (See Evidence Table, Supplemental Digital Content 6,
http://links.lww.com/NEU/A638).
Data Synthesis
Four publications met the criteria and are included as evidence for
this question.6,8,13,14 All took place in athletic environments: 2 with
adults and 2 combining adults and adolescents. Two studies
compared differences on outcome measures between players with
and without previous concussions.6,13 Collins et al6 also assessed the
influence of learning disability on outcome. One study8 assessed sex
differences, and 1 study14 assessed differences in outcomes between
white and black subjects.
Results
A detailed analysis of the data from the included studies on
subgroup differences can be found in Supplemental Digital
FIGURE 1. Proportion of cognitive tests with group differences across time.
TABLE 5. Cognitive Test Frequency by Cognitive Domain and
Outcome
Tests,
n
Proportion
Positive, %
Studies,
n
Reaction time 6 83 3
Attention/processing speed/
working memory
15 29 4
Memory 53 43 8
Executive function 16 6 3
Motor/sensory 8 12.5 5
PREVALENT INDICATORS OF CONCUSSION
NEUROSURGERY VOLUME 75 | NUMBER 3 | SEPTEMBER 2014 SUPPLEMENT | S9
Content 9, Analysis (http://links.lww.com/NEU/A641), sum-
marized as follows:
Previous Concussions. Evidence from 1 study suggests that
athletes who sustained prior concussions had lower preinjury
baseline scores on 2 of 9 (22%) neuropsychological tests (Trails B
and Symbol Digit) than those with no history of concussion.6
A second study suggests that the odds of sustaining a 14-point
drop in the ImPACT Memory Index within 5 days of injury are
7 to 8 times greater for athletes who sustained prior concussions
than those with no history of concussion; a difference was found
in 1 of 3 tests (33%) for this study.13
Learning Disability. One study suggests no influence of learning
disability on preinjury baseline neuropsychological tests among
male athletes.6
Sex. One study suggests that on 1 of 4 ImPACT measures
(25%), Visual Memory, female subjects had significantly lower
scores than male subjects when measured at a range of 1 to 3 days
after injury.8
Race. One study suggests that at 7 days after injury, black athletes
are 2.4 timesmore likely to have a clinically significant decline on 1
of the 4 ImPACT measures than white athletes.14
Key Question 3 Results
Key Question 3: What is the association between different
signs, symptoms, and deficits or between the same signs,
symptoms, or deficits at different time points for the same
patient after a PCE? (See Evidence Table, Supplemental
Digital Content 6, http://links.lww.com/NEU/A638).
Data Synthesis
Four publicationsmet the criteria andwere included as evidence
for this question.4,9,15,18 Three took place in athletic environ-
ments: 1 with adults, 1 with adolescents, and 1 combining adults
and adolescents. A fourth study assessed adult and pediatric
hospital patients.9 Three studies examined the relationship
between signs (severity estimates) and measures of function on
cognitive tests.9,15,18 One examined the association between
symptoms and cognitive function.4
Results
A detailed analysis of the data from the included studies
on associations among signs, symptoms, and deficits can
be found in Supplemental Digital Content 9, Analysis
(http://links.lww.com/NEU/A641), summarized as follows:
Signs and Cognitive Function: Severity of Injury. Evidence from
1 study suggests that athletes who sustain a PCE and have amnesia
or disorientation for.5 minutes after injury may have significant
reduction in memory function up to 7 days after injury and that
those with amnesia or disorientation for ,5 minutes may have
significant reduction in memory function up to 4 days after
injury.15 A second study suggests that athletes with both LOC
and PTA after a PCE may have significant reduction in function
as measured by the Standardized Assessment of Concussion
immediately after injury compared with those with PTA alone or
those with neither LOC or PTA, and that those with PTA alone
may have significant reduction in function compared with those
with neither LOC or PTA.18 A third study suggests that function
as measured by performance on the Digit Symbol test within
24 hours of injury may be significantly lower for hospital patients
with PTA than those without PTA.9
Symptoms and Cognitive Function. One study reported a signifi-
cant correlation between subjective reports of symptoms and
objectivemeasures of cognitive function and balance within 48 hours
of injury.4 Significant correlations were between the following:
Feeling mentally foggy and reaction time (P = .03)
Difficulty concentrating and verbal memory (P = .01)
Difficulty remembering and verbal memory (P , .001) and
reaction time (P = .03)
Balance problems and the SOT composite (P , .001),
somatosensory ratio (P = .03), visual ratio (P = .04), and
vestibular ratio (P , .001)
Dizziness and the SOT composite (P , .001) and vestibular
ratio (P = .01)
Key Question 4 Results
Key Question 4: What is the relationship between
signs, symptoms, and deficits and imaging or biomarkers
after a PCE? (See Evidence Table, Supplemental Digital
Content 7, http://links.lww.com/NEU/A639).
Data Synthesis
Seven publications met the criteria and were included as
evidence for this question.11,21-24,26,27 Four reported on the
relationship between CT scans and SSDs,21,24,26,27 and 3 re-
ported on biomarkers and SSDs.11,22,23 All took place in hospital
FIGURE 2. Proportion of cognitive tests with group differences across domains.
Att/PS/WM, attention/processing speed/working memory; Fx, function; RT,
reaction time.
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environments: 4 with adult samples, 2 with adult and pediatric
patients, and 1 with pediatric patients only.
Results
A detailed analysis of the data from the included studies
on associations between SSDs and imaging or biomarkers
can be found in Supplemental Digital Content 9, Analysis
(http://links.lww.com/NEU/A641), summarized as follows:
CT Scan. In the 4 publications assessing CT imaging, a total
of 4803 patients were scanned within 24 hours of injury.
Of those, 360 patients had positive findings onCT scan (7.5%);
the prevalence of positive findings across studies ranged
from 4.7% to 19% (see Table, Supplemental Digital Content
15 [http://links.lww.com/NEU/A647] for confidence intervals
and odds ratios).
Signs. One study showed a significant relationship between
CT and LOC/amnesia, 2 for Glasgow Coma Scale (GCS) score of
13, 1 for PTA .4 hours, and 4 for vomiting.
Symptoms, Neurologic Deficits, and Cognitive Deficits. The
data on the association between CT and symptoms and neurologic
deficits are contradictory or equivocal (see Table, Supplemental
Digital Content 15, http://links.lww.com/NEU/A647). No
study meeting inclusion criteria considered the association
between CT and measures of cognitive function.
Biomarkers. Limited evidence from single studies about
the associations between signs/symptoms/objective measures of
neurologic and cognitive function and biomarkers shows that GCS
score (13-14 vs 15) is correlated with serum levels of ubiquitin
C-terminal hydrolasewithin 4hours of injury22 and that GCS score
(13-14 vs 15) is correlated with serum levels of glial fibrillary acidic
protein breakdown products within 4 hours of injury.23
DISCUSSION
Objectives
The objectives of this project were to conduct a systematic
review of the highest-quality literature about concussion and to
assemble evidence about the prevalence and associations of key
indicators of concussion. The goal was to establish an evidence-
based foundation from which to derive, in future work, a defini-
tion, diagnostic criteria, and prognostic indicators of concussion.
Summary of Relevant Findings
Prevalent Indicators
Replicated data from studies that met the prespecified inclusion
criteria with medium potential for bias and confound suggest
that prevalent and consistent indicators of concussion are the
following:
• Observed and documented disorientation or confusion imme-
diately after the event,
• Impaired balance within 1 day after injury,
• Slower reaction time within 2 days after injury, and/or
• Impaired verbal learning and memory within 2 days after injury.
Recovery Patterns in Tests of Cognitive Function
For the studies included in this review, the proportion of tests
that showed decrements in cognitive function (absolute differ-
ences between PCEs and comparators) decreased from 58% on
day 1 to 8% on day 7. This finding could indicate that in the
majority of cases cognitive deficits resolve within 1 week.
Tests Showing Deficits in Cognitive Function
Tests of reaction time, memory, and attention/processing
speed/working memory most consistently showed deficits in
cognitive function within the first week of injury.
Subgroups
Individuals with a history of previous concussions had lower
scores than those without previous concussions on tests of
cognitive function from baseline to 5 days after injury.
Associations
Severity of injury, measured by duration of amnesia or
disorientation or the presence or absence of LOC and PTA, was
associated with deficits in cognitive function up to 7 days after
injury.
Self-reported symptoms may be associated with neurologic and
cognitive deficits within 48 hours of injury.
Positive findings onCT imaging were associatedwith indicators
of having sustained a PCE, measured by LOC/amnesia, a GCS
score of 13, and vomiting; however, those measures are not linked
to having sustained a concussion.
Serum levels of ubiquitin C-terminal hydrolase and glial
fibrillary acidic protein breakdown products may be associated
with an indication of having sustained a PCE, measured by a GCS
score of 13 to 14; however, this measure was not linked to having
sustained a concussion.
Limitations of This Review
A major limitation of this review is that most of the studies
meeting inclusion and quality criteria were from athletic environ-
ments. The limited findings can be generalized only to similar
populations, leaving unanswered questions about the feasibility,
applicability, and utility of measurement instruments and findings
in other populations such as patients seen in healthcare facilities or
deployed military.
Another limitation is the lack of a definition for concussion.
This review aims to identify prevalent indicators of concussion.
However, as stated earlier, without a definition for concussion, the
findings of this review can be viewed only as indicators of some
phenomenon that is being called concussion.
Finally, the signs, symptoms, and deficits at the time points
indicated that constitute the prevalent indicators are whatwas found
in the existing literature from studies that met the prespecified
inclusion criteria and adhered to standards for minimizing potential
for bias and confound. The absence of evidence for other impair-
ments at other time pointsmust not be interpreted as evidence of no
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impairment. The evidence for these conclusions should be used as
a starting point from which to identify missing information as
targets for future investigation.
Practice Effects and Test Reliability
The ability of neuropsychological tests to detect deficits
indicative of concussion is in question. Even with conditions
more severe than concussion, many cognitive tests can be
confoundedby factorsunrelated to the injuryordisease.29 Relevant
to this review, scores can improve as a result of repeated test
exposure over a short period of time (eg, multiple tests within
7 days of injury).
Six of the 8 studies used to identify prevalent indicators in this
report used cognitive tests. Two used average scores without
separate control groups as comparators (eg, preinjury baseline
scores were used to control),3,14 and although a third study used
a control group, those data were not reported.28 Therefore, an
assessment of practice effects cannot be made with these studies.
Three studies used average scores with separate control groups as
comparators.6,10,15 Although the use of average scores limits the
ability to assess practice effects, there is some evidence of practice
effects from days 5 to 7 in these studies.
Limitations of the Literature
Although there is an abundance of research about concussion—
the search captured 1362 potentially relevant publications—
many studies were excluded because they did not provide
information that could be used to determine the prevalence of
and associations among indicators of concussion. Primary reasons
for excluding studies or not using them in the final analysis
include the following:
Lack of Comparison Groups
Signs and symptoms considered potential indicators of con-
cussion are also common in nonconcussed populations. Thus, data
from samples without comparators overestimate the prevalence of
SSDs in the samples.
Mixed Patient Populations
Some samples included other pathologies or included the full
spectrum of severity of traumatic brain injury.
Time From Injury Not Specified
Many samples included individuals whose chronicity varied.
Some ranged from days to decades in the same sample. Some
studies did not report time from injury.
Measures Not Validated
Some investigators adapted standardized measures; others
formulated their own measures without validation data. Some
studies used self-report or caregiver report of cognitive measures.
Data Reported as Composite Scores
Many composite scores combine a number of questions or tests
that collapse individual SSDs into an aggregate. This form of
reporting, although useful for some analyses, masks the informa-
tion needed to identify individual indicators.
High Potential for Bias or Confound
As described in the Methods section of this report, each
included study was assessed for potential for bias and confound
across 7 domains. For each domain, each study was rated
as minimized bias, did not minimize bias, or unclear. Table 6
summarizes the results of these assessments for studies used to
address Key Questions 1 and 2. Lack of clarity in reporting
accounts for much of the high potential for bias and confound.
Exclusive Case Definitions
Most studies prespecified concussion, selected the individuals
who met the prespecified criteria for their study samples, and
measured them for targeted outcomes. This would have been
a reasonable approach if concussion were defined and the true
presence or absence of concussion could be identified in the
sample. That was not the case. The result is that the probability of
subjects having the outcomes of interest was increased by the
inclusion criteria. In addition, with many of the studies conducted
in hospital settings, allocation into PCE or control groups was
determined on the basis of specific signs or symptoms. Although
limiting inclusion criteria serves the purpose of having a clearly
defined sample, it minimizes the utility of the data for the purpose
of identifying prevalent indicators.
Lack of Correlational Analyses
The most striking gap appears to be the lack of simple
correlational analyses among SSDs and across time. Some studies
TABLE 6. Assessment of Potential for Bias and Confound (Key
Questions 1 and 2)a
Minimized,
n
Did Not
Minimize,
n
Unclear,
n
Selection bias 25 26 142
Bias resulting from missing data 68 38 87
Ascertainment bias resulting
from case definition and
identification
121 15 57
Ascertainment bias resulting
from case assessment
5 8 180
Bias resulting from SSD
description and evaluation
75 2 116
Bias resulting from SSD
assessment
4 18 171
Confounding 93 23 77
aSSD, signs, symptoms, neurologic deficits, and cognitive deficits.
CARNEY ET AL
S12 | VOLUME 75 | NUMBER 3 | SEPTEMBER 2014 SUPPLEMENT www.neurosurgery-online.com
reported proportions of the samples with specific SSDs at specific
time points but did not correlate them. Other studies conducted
sophisticated factor analyses demonstrating clustering of SSDs but
reported results in terms of hypothesized latent variables, thus
masking the information needed to identify specific indicators.
Analysis of Group Means on Outcome Measures
Using group averages for samples of potentially concussed
individuals has limited value. The “concussed” patient population
appears to have signs, symptoms, and deficits that are subtle and
difficult to detect. In addition, from the available evidence, it
appears that a relatively small proportion of individuals sustaining
a concussion show the signs and symptoms commonly thought to
be signature indicators of concussion. That problem is amplified
by averaging measures such as response time or immediate recall
across the entire sample of PCE participants. Data presented in
proportions of patients with specific signs, symptoms, and deficits
would be more useful in identifying prevalent indicators.
Measurement Time Points
Measurement time points in the available literature were not
well suited for identifying prevalent indicators of concussion.
Many studies took 1 or 2 measures during the first week and then
again at 1 and/or 3 months after injury. From the results of this
report, it appears that most SSDs associated with concussion
resolve within a week of the injury. More research is needed to
confirm this finding. If true, the information does not mitigate the
need to address the long-term deficits sustained by the smaller
number of concussed patients who do not recover. However, what
is needed is a set of studies that take measures more consistently
during the first several weeks after a PCE. With that, accurate
recovery curves could be plotted for the observed SSDs.
Contradictory Evidence
In this analysis, we found cases in which 2 similar studies showed
opposite (contradictory) findings for group differences on specific
measures at specific time points. When contradictory findings
between 2 studies occurred, there were differences in control groups
(self as controls vs control group),methods of analysis (groupmeans
vs a reliable change index), or population ages (mixed sample of high
school and college students vs separate). Variations in these 3 study
characteristics (and others not yet identified) could account for the
observed differences in results.
Future Research
Study Design Recommendations
Evidence for Concussion vs Evidence for a PCE. An important
distinction that needs to be clarified and used to design future
studies more precisely is the distinction between evidence for
concussion and evidence for a PCE.
In the absence of a physiologic measure, what is available to use
as evidence for a concussion are signs, symptoms, and objective
measures of neurologic or cognitive dysfunction. In addition,
brain imaging, biomarkers, helmet accelerometer studies, and
other objective methods are being explored for their ability to
detect concussion. However, studies have not examined the links
among these measures in a way that distinguishes evidence for
concussion from evidence for a PCE.
For example, a forehead laceration after a fall is evidence for
a PCEbut not necessarily for a concussion. Similarly, an increase in
the level of a brain-specific serum protein after a PCEmay confirm
that an impact occurred but does not necessarily confirm that
a concussion occurred. Recent studies of imaging and biomarkers
provide the groundwork for investigating the relationship between
these measures (evidence for a PCE) and objective measures of
dysfunction (evidence for a concussion).22,23,30 Future research
should clearly distinguish between indicators of a PCE and
indicators of a concussion and should analyze the associations
between them to find if, and under which circumstances,
evidence for a PCE can reliably be used to indicate a high
probability of a concussion.
Distinguish Concussion From Other Phenomena. A critical gap in
research on concussion is the lack of distinction between which
signs, symptoms, anddeficits are specific to concussion andwhich are
also indicators of other pathologies or of transient, nonpathological
conditions such as fatigue. This gap exists because most studies
include andmeasure only individuals who sustained a PCE. Table 7
is an outline of a study recommended to clarify the distinction
between concussion and other phenomena. This is intended to be
an outline only and does not specify operational definitions and
other critical information required for a complete design.
If well conducted, this study would provide data on concussion
at multiple levels, including (1) detected vs undetected PCE; (2)
association between force of impact and observed PCEs vs no
observed PCEs; (3) changes in individual presentation of signs,
symptoms, deficits, and serumproteins for different levels of force of
impact (including no impact) and for observed PCEs vs no observed
PCEs; and (4) association between signs, symptoms, deficits, serum
proteins, and imaging for different levels of force of impact
(including no impact) and for observed PCEs vs no observed PCEs.
Findings would be specific to college-level male subjects in an
athletic setting (direct evidence). The next stepwould be to consider
towhat extent the findings could be generalized to other populations
(indirect evidence). Information from a study conducted in an
athletic setting would be considered indirect evidence if applied to
hospital or battlefield settings. Indirect evidence may not provide
a degree of confidence as strong as direct evidence from well-
designed and well-conducted studies. There are, however, protocols
for using indirect evidence that are derived from evidence-based
principles and used in the development of guidelines.31 These
protocols could be used to consider generalizability of findings.
Given the difficulties inherent in collecting data under certain
circumstances (such as armed conflict), the development of reliable
methods for acquiring indirect evidence should be a priority. In
addition, the activity of conducting a comprehensive and rigorous
prospective study in an athletic setting could lay the groundwork
for what would be required to conduct a well-controlled study in
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more volatile environments. It could also serve to clarify which
specific questions, unique only to battlefield environments, remain
unanswered and need to be addressed.
Road Map From Indicators to Diagnostic Criteria
This project accomplished the assembly of evidence about the
prevalent indicators of concussion. The next step, which will be
undertaken by the authors of this report, is to derive diagnostic
criteria that are evidence-based and clinically useful. The proposed
working definition for diagnostic criteria is given below:
Diagnostic criteria are the essential attributes and the pattern or
relationship among those attributes used to identify a case.
The development of diagnostic criteria takes the prevalent
indicators and identifies the consistent patterns among them. The
following roadmap from indicators to diagnostic criteria is proposed:
There are a set of publications from large cohort studies rated as
medium potential for bias that appear to have accomplished
extensive data collection. They did not, however, report the data in
a way that could be used to provide evidence for a definition or to
derive diagnostic criteria. However, the necessary data exist, and
preliminary inquiries indicate that they would be available for
secondary analysis. These data sets are a potential source of
information that could be analyzed with the use of simple
frequency and correlational methods to derive more evidence to
derive a definition and diagnostic criteria.
This project, the Raw Dataset Review (RaDaR), was initiated
in July 2012 (funded by the US Army Contracting Command).
The objectives of RaDaR are to acquire existing sets of data from
studies about concussion or mild traumatic brain injury; to
organize and analyze them to identify the frequency of specific
signs, symptoms, and deficits across time; to analyze them to
identify the correlations among them over time; and to use the
findings to modify the evidence base for the prevalent indicators.
It is expected that someof the existing indicatorswill be confirmed;
some of the existing indicators will not be confirmed and may be
dropped from the evidence base; new indicators will be identified and
be added to the evidence base; and relationships among indicators
will be identified, providing the framework for diagnostic criteria.
The product will be a set of evidence-based indicators and their
associations to be used as candidate diagnostic criteria for
concussion. Subsequent work will involve validating the candidate
criteria in retrospective and prospective studies.
CONCLUSION
At this time, there are no known objective measures to identify
the change in brain function called concussion. Consequently,
TABLE 7. Proposed Study Design: Concussion
Population All members of a college football team (or set of teams), including those who do not play
Comparators Self as own controls from preseason baseline testing
Baseline measures Demographics, education and intelligence quotient, preexisting conditions, previous concussions, symptoms
Pregame measures Symptoms
Balance
Cognitive
Serum proteins
Imaging
In-play measures Force of impact (helmets equipped to measure force)
Observed potential concussive events
Signs
Symptoms
Postgame measures (immediate) Signs
Symptoms
Balance
Cognitive
Serum proteins
Imaging
Follow-up measures Signs
Symptoms
Balance
Cognitive
Serum proteins
Imaging
Follow-up timing 3 h; 1, 2, 3, 5, and 7 d; 2 wk; 1 mo
Data Frequencies
Correlations
Additional analyses, prespecified according to specific research questions
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observed signs, subjective reports, and objective measures of
neurologic and cognitive function that may be indicators of the
underlying change in brain function are used to identify
individuals with a high likelihood of having a concussion.
The task of this project was to identify which signs, symptoms,
and neurologic and cognitive deficits have the highest and most
consistent prevalence in samples of individuals sustaining a PCE
and to assess how they are associated. From the available evidence,
slowed reaction time, impaired verbal learning and memory,
impaired balance, and disorientation or confusion were found to
be significantly prevalent in early samples of exposed individuals.
There is insufficient evidence to assess the relationships among
these measures.
At aminimum, future studies should include comparison groups;
takemeasures at fixed and relevant time points; report distinct signs,
symptoms, and deficits in terms of frequencies and correlations; and
follow standards for minimizing bias and confound.
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